Test Price
2,800 AED✅ Home Collection Available
ADAMTS13 Gene Thrombotic Thrombocytopenic Purpura (TTP) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
✔ 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
✔ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, 8 AM – 11 PM daily.
✔ Clinical Guidance: Telephonic Post-Test Clinical Correlation by DHA-Licensed Consultant Medical Geneticist.
✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent procedures align with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
The ADAMTS13 Gene TTP Genetic Test determines carrier status and guides lifelong prophylactic plasma therapy through definitive molecular diagnosis of congenital thrombotic thrombocytopenic purpura (TTP). Using targeted Next Generation Sequencing (NGS) with full gene coverage, the test identifies mutations across all exons and intronic regions of ADAMTS13, achieving ultra-high diagnostic precision.
| Feature | Our ADAMTS13 NGS Test | Alternative: Whole Exome Sequencing (WES) |
|---|---|---|
| Method | Targeted NGS – full gene coverage | Exome-wide sequencing; may miss deep intronic ADAMTS13 variants |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Precision | Ultra-high coverage for ADAMTS13; resolves all mutation types | Moderate coverage; risk of false negatives in certain regions |
| Cost | 2800 AED | ~4500 AED |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that the ADAMTS13 NGS test provides definitive molecular diagnosis for congenital TTP. However, results must always be interpreted alongside clinical findings and ADAMTS13 activity levels. Genetic counseling is essential for affected families.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
⚠️ Medication Safety Alert
Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic purposes and does not replace ongoing therapy. Always consult your specialist before changing any medication regimen.
Exclusion Criteria & Emergency Red Flags
- Recent blood transfusion (< 2 weeks) or allogeneic stem cell transplant – contact our genetic counselor for buccal swab alternative.
- Acute TTP symptoms: chest pain, severe headache, confusion, seizures, uncontrolled bleeding, or fever with thrombocytopenia – seek immediate emergency care.
- Pregnancy – requires specialist clearance before venipuncture.
Patient FAQ & Clinical Guidance
1. What is the ADAMTS13 gene test and why do I need it?
Direct Answer: This NGS test definitively identifies genetic mutations causing congenital thrombotic thrombocytopenic purpura (TTP), a rare life-threatening clotting disorder.
It is recommended for individuals with unexplained recurrent microangiopathic hemolytic anemia and thrombocytopenia, especially if other family members are affected. Results enable precise diagnosis and prophylactic plasma infusion planning.
2. How is this test performed and what is the turnaround time?
Direct Answer: Blood DNA is sequenced via NGS to analyze ADAMTS13, providing results in 3–4 weeks.
A simple blood draw or FTA card sample is collected at our cold-chain home service. DNA is extracted and the entire ADAMTS13 gene is sequenced with high coverage. A comprehensive report is issued within 21–28 calendar days.
3. What do my results mean and how will they guide treatment?
Direct Answer: Results reveal mutation status, confirming congenital TTP or carrier status, enabling personalized prophylactic plasma infusion therapy.
A positive result indicates hereditary TTP and the need for regular prophylactic plasma infusions to maintain ADAMTS13 levels. Carrier detection helps with family planning. All findings are interpreted by our DHA-licensed consultant medical geneticist and genetic counselor.
4. What are the pre-test requirements and collection details?
Direct Answer: Provide detailed clinical history and family pedigree chart during pre-genetic counseling session. No fasting required; continue regular medications unless instructed otherwise.
Specimen: 2 mL whole blood in EDTA or DNA FTA card (provided in home collection kit). Home collection is available daily from 8 AM to 11 PM across all UAE Emirates. Schedule via WhatsApp +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
All genetic testing and patient data handling are conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted, anonymized, and used solely for diagnostic purposes. You retain the right to access, correct, and request deletion of your data under PDPL.
Clinical & Logistical Metadata
| Test Name | ADAMTS13 Gene Thrombotic Thrombocytopenic Purpura (TTP) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | M31.1 |
| LOINC Code | 81311-5 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians